Clinical Trials Directory

Trials / Completed

CompletedNCT04358952

Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients

Imaging Cardiac Phenotype of SARS-Cov-2 (Covid19) Infected Patients

Status
Completed
Phase
Study type
Observational
Enrollment
122 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The effects of severe acute respiratory syndrome SARS-Cov-2 (Covid-19) on the myocardium and their role in the clinical course of infected patients are still unknown. Epidemiological studies report biological myocardial involvement in 10 to 25% of cases. The objective of this study is to cardiac phenotype using comprehensive cardiac imaging tools of patients infected with Covid 19 in order to explore the functional impact of the infection on the myocardium.

Detailed description

A large population of Covid 19 infected patients of different ages and severity levels will be explored by transthoracic echocardiography with measurement of myocardial functional parameters such as ejection fraction, longitudinal strain and relaxation parameters and will be compared to an uninfected population paired for age and sex. Patients with biological myocardial involvement will be followed to determine the evolution of their myocardial functional parameters during the course of the infection.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGlobal Longitudinal StrainElectrocardiogram with measure of the Global Longitudinal Strain to evaluate myocardiac dysfunction

Timeline

Start date
2020-04-04
Primary completion
2021-04-02
Completion
2021-04-02
First posted
2020-04-24
Last updated
2021-06-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04358952. Inclusion in this directory is not an endorsement.